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ABSTRACT
Enterovirus 71 (EV71) is associated with severe
neurological disorders in children, and has been
implicated as the infectious agent in several large-
scale outbreaks with mortalities. Upon infection, the
viral RNA is translated in a cap-independent manner
to yield a large polyprotein precursor. This mechan-
ism relies on the presence of an internal ribosome
entry site (IRES) element within the 50-untranslated
region. Virus–host interactions in EV71-infected
cells are crucial in assisting this process. We
identified a novel positive IRES trans-acting factor,
far upstream element binding protein 1 (FBP1).
Using binding assays, we mapped the RNA deter-
minants within the EV71 IRES responsible for FBP1
binding and mapped the protein domains involved in
this interaction. We also demonstrated that during
EV71 infection, the nuclear protein FBP1 is enriched
in cytoplasm where viral replication occurs. Moreover,
we showed that FBP1 acts as a positive regulator of
EV71 replication by competing with negative ITAF
for EV71 IRES binding. These new findings may
provide a route to new anti-viral therapy.
INTRODUCTION
EV71 has been implicated as the etiological agent in several
large-scale outbreaks of severe neurological disorders
worldwide. EV71 infections usually cause hand foot and
mouth disease (HFMD) and severe neurological compli-
cations with mortality (1). Children are susceptible to the
EV71-associated fatal pulmonary edema and hemorrhage.
In 1998, an EV71 infection epidemic occurred in Taiwan,
with the virus infecting over 120000 people and killing 78
children (2,3). Many EV71 smaller scale epidemics also
occurred after 1998 on the island. In recent years, many
EV71 epidemics have occurred throughout the Asia-
Paciﬁc region, in Taiwan, mainland China, Malaysia,
Singapore, Western Australia, the USA and Europe
(1,4–9). In 2008, 488 955 HFMD cases and 126 fatal cases
were reported in mainland China, and EV71 was the
major pathogen (10).
EV71 is a member of the genus Enterovirus, family
Picornaviridae, and is a single-stranded, positive sense,
RNA virus (11). After infection of the host cells, the gen-
ome is translated in a cap-independent manner into a
single polyprotein, which is subsequently processed by
virus-encoded proteases into structural capsid proteins
and non-structural proteins. Non-structural proteins are
mainly involved in the replication of the virus. The viral
genomic RNA is  7500nt. The 745nt of the 50-untrans-
lated region (50-UTR) contains a cloverleaf structure es-
sential for viral RNA replication and an internal ribosome
entry site (IRES) that directs initiation of translation in a
cap-independent manner (12). The cloverleaf structure is a
multifunctional cis-acting replication element, which inter-
acts with viral and cellular proteins to form a
ribonucleoprotein complex (13).
The EV71 IRES element contains ﬁve major stem–loops
(domain II–VI) and has been shown to be functionally
similar to type I IRESs such as poliovirus IRES (12).
During the internal initiation on type I IRES, the ribosome
is recruited by eIF4G to a silent AUG within domain V
and then scans through an unstructured region to reach
the authentic AUG start codon and initiate translation
(14). No RNA secondary structure is predicted between
the EV71 IRES domain VI and the ﬁrst AUG codon
(637–745nt), and we deﬁned this region as a ‘linker’.
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Recently, several studies have highlighted the role of the
cellular proteins known as IRES trans-acting factors
(ITAF), in assisting the independent initiation process.
Cellular proteins including polypyrimidine tract binding
protein (PTB), poly(rC)-binding protein 1 (PCBP1),
poly(rC)-binding protein 2 (PCBP2), autoantigen La,
upstream N-ras protein (Unr) and ITAF45, have been
shown to be involved in picornaviral IRES-mediated
translation (15–21). There is evidence that these proteins
acts as RNA chaperones to assists ribosome recruitment
to viral IRESs (20,21). To gain insights into the host–virus
interactions regulating translation during EV71 infection,
we used a biotinylated RNA–protein pull-down approach
followed by matrix-assisted laser desorption ionization/
time-of-ﬂight mass spectrometer (MALDI-TOF)
analysis. This identiﬁed 12 cellular proteins potentially
involved in EV71 IRES-mediated translation (18,22). We
previously characterized the role of the far upstream elem-
ent binding protein 2 (FBP2) as a negative regulator for
EV71 IRES activity (22). In this study, we further
investigated the role of another FBP protein, FBP1.
FBP1 has been reported to bind to the human c-myc far
upstream element (FUSE) and regulate transcription of
c-myc (23,24). The transcriptional activation domain is
located in the C-terminus of FBP1 through a tyrosine
activating sequence (25). Four KH-motifs are important
for binding DNA or RNA by the amphipathic helix in the
central domain of FBP1 (23). FBP1 is a nuclear protein
and contains three nuclear-localization signals (NLS), a
classical bipartite NLS in the N-terminal, a a-helix in
the third KH-motif, and a tyrosine-rich motif in the
C-terminal of FBP1 (26). FBP1 can interact with the
poly(U) tract of the 30-NTR and Hepatitis C virus
(HCV) NS5A polymerase, which is essential for efﬁcient
replication of HCV (27). The FBP1 interacts with untrans-
lated regions of Japanese encephalitis virus RNA and
negatively regulates viral replication (28). In this study,
we show that FBP1 acts as a novel positive ITAF for
EV71, opposite from the negative role of the previously
identiﬁed FBP2. Interaction regions within EV71 50-UTR
and FBP1 were mapped and the impact of IRES–FBP1
interaction on viral IRES activity, viral translation and
replication are examined. Our results demonstrate that
the linker region is responsible for the recruitment of
FBP1 to the viral RNA and that FBP1 outcompetes
with FBP2 to positively regulation the translation of
viral proteins. These results expand our knowledge of
the network of interaction between viral IRESs and
cellular factor that ﬁne-tunes internal entry of ribosome,
providing new insights into translational control during
viral infection.
MATERIALS AND METHODS
Plasmid construction
The pT7-EV71-50-UTR was constructed as follows. The
50-UTR of EV71 was ampliﬁed by PCR from the EV71
full-length infectious cDNA clone using EV71 50-(GCCG
GTAATACGACTCACTATAGGGAGATTAAAACA
GCCTGTGGGT) primer which contained the T7
promoter and EV71 50-(CATGTTTGATTGTGTTGAGG
GTCAAAAT) primer. It was then cloned into a pCRII-
TOPO vector by TA cloning (Invitrogen, CA, USA) (22).
The pCMV-tag2B-FBP1 was utilized to construct vari-
ous truncated forms of ﬂag-tagged KH-motifs of FBP1,
PCR products were subcloned between the EcoRI and
XhoI sites of the pCMV-tag2B vector.
The pGL3-EV71-50-UTR-Fluc was constructed by
PCR-ampliﬁed fragment of EV71 50-UTR from pT7-
EV71-50-UTR plasmid (22).
Plasmid p3EGFP-C3 is a reporter plasmid that contains
three copies of the EGFP gene that are fused in frame. The
plasmid was constructed by inserting an EGFP DNA
fragment, which was ampliﬁed with primers 50-(TGTAC
AAGTACTCAATGGTGAGCAAGGGCGAG) and
50-(CTTGAGCTCGAGCTTGTACAGCTCGTCCAT)
from pEGFP-C3 digested with SalI and XhoI, and
inserted into the SalI–XhoI sites in pEGFP-C3. Another
EGFP DNA fragment, which was ampliﬁed using primers
50-(GAGCTCAAGCTTATGGTGAGCAAGGGCGAG)
and 50-(ACTGCAGAATTCGCTTGTACAGCTCGTCC
AT), was digested with HindIII and EcoRI and inserted
into the HindIII–EcoRI sites. Plasmid pFBP(63/78) was
constructed by inserting a PCR-ampliﬁed DNA fragment
that encodes the region between amino acids 63 and 78,
into the p3EGFP. Plasmids pFBP(366/386) and pFBP(531/
634), which contain DNA fragments that encode the FBP
regions from amino acids 366 to 386 and 531to 634, re-
spectively, were constructed using the same method (29).
The pBacPAK8-MTEGFP-FBP1 was utilized to
express recombinant FBP1 by the baculovirus expression
system. The cDNA of FBP1 was ampliﬁed by PCR using
50-(CCGCTCGAGGCCACCATGGCAGACTATTCAA
CAGTG) and 50-(CCGGAATTCTCAATGATGATGAT
GATGGTGTTGGCCCTGAGGTGCTGG) primers
which contained six His sequence. After ampliﬁcation,
this was inserted into pBacPAK8-MTEGFP vector (gift
from Dr Tsu-An Hsu, Nation Health Research Institutes,
Taiwan) using XhoI and EcoRI.
In vitro transcription
The T7 promoter-EV71 50-UTR DNA fragment cleaved by
the EcoRI enzyme was excised from the vector pCRII-
TOPO. RNA transcript probes were synthesized using a
MEGAscript T7 kit (Ambion, TX, USA), following the
protocol provided by the manufacturer. A biotinylated
RNA probe synthesized in a 20ml MEGAscript transcrip-
tion reaction by adding 1.25ml 20mM biotinylated UTP,
Biotin-16-UTP (Roche). The synthesized RNA probes
were puriﬁed using an RNeasy Protect Mini kit (Nobel).
Preparation of cell extracts
SK-N-MC (human neuroblastoma), SF268 (human glio-
blastoma), RD (human embryonal rhabdomyosarcoma)
and Vero cells (African green monkey kidney epithelial
cells) were grown in Dulbecco’s Modiﬁed Eagle medium
(DMEM) (GIBCO, CA, USA) containing 10% (v/v) fetal
bovine serum (FBS) and antibiotics. Whole cells were
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phosphate-buffered saline (PBS). Then, the cells were re-
suspended in CHAPS buffer (10mM Tris–HCl pH 7.4,
1mM MgCl2, 1mM EGTA, 0.5% CHAPS, 10%
glycerol, 0.1mM PMSF, 5mM 2-ME), and incubated
30min on ice for lysing. The cell lysates were obtained
by centrifugation at 10000g for 10min at 4 C. The
pellets were discarded. The supernatants were collected,
immediately frozen and stored at  80 C. The protein con-
centration was determined using the Bio-Rad protein
assay (Bio-Rad).
Pull-down assay by Streptavidin bead and biotinylated
RNA probe
The reaction mixture contained 200mg of cell extracts and
3mg of biotinylated EV71 50-UTR RNA probe. The
reaction mixture’s ﬁnal volume was adjusted to 100ml
with RNA mobility shift buffer (5mM HEPES, 40mM
KCl, 0.1mM EDTA, 2mM MgCl2, 2mM dithiothreitol,
1U RNasin and 0.25mg/ml heparin). The mixture was
incubated for 15min at 30 C, and then added to 400ml
of Streptavidin MagneSphere Paramagnetic Particles
(Promega) for binding at room temperature for 10min.
Then, the RNA–protein complexes were washed seven
times with the RNA mobility shift buffer without heparin.
After washing, 15mlo f6   SDS–PAGE sample buffer was
added to the reaction mixture. The reaction mixtures were
incubated for 10min at room temperature to separate the
proteins from the RNA. The eluted proteins were boiled,
subjected to 12% SDS–PAGE, and then transferred to
PVDF membranes. The membranes were blocked for 2h
at room temperature using 5% non-fat dry milk in Tris-
buffered saline buffer containing 0.1% Tween-20. The
membrane was then washed ﬁve times with the same buffer
and treated overnight at 4 C with an antibody against
FBP1 (1:200; Santa Cruz Biotechnology). The membrane
was washed with the same buffer ﬁve times, then treated
with a 1:5000 dilution of horseradish peroxidase (HRP)-
conjugated anti-goat antibody for 1h at room tempera-
ture, and washed thoroughly. The membrane was
incubated with HRP substrate (Western Lightning chemi-
luminescence reagent; Amersham Pharmacia) for 2min,
exposed on ﬁlm and developed.
Electrophoretic mobility shift assays
For electrophoretic mobility shift assays, RNAs were dir-
ectly transcribed using T7 RNA polymerase from PCR
products containing the T7 polymerase promoter sequence
and puriﬁed as previously described (30). The cold com-
petitor RNAs were transcribed from PCR products gene-
rated using the following primer T7-UTRstart: 50-(TAAT
ACGACTCACTATAGGGAGATTAAAACAGCCTGT
GGGTTG),T7-636: 50-(TAATACGACTCACTATAGG
GAGAATCCGGTGTGCAACAGGGCAATTG), and
the following primer as a 30-end primer: 50-(CATGTTT
GATTG TGTTGAGGGTC). The
32P-labeled RNAs
were transcribed from PCR products generated using the
same 50- and 30-primers in the presence of a-
32P-UTP.
For electrophoretic mobility shift assays with competi-
tor RNAs, the 50fmol of
32P labeled RNA with 2pmol
FBP1 was followed by 20min 37 C incubation with
2pmol cold competitor RNA or 10pmol tRNA. RNP
complexes were formed in buffer B (20mM Tris pH 7.6,
100mM KCl, 2mM MgCl2 and 2mM DTT). The free
RNA and RNP complexes were fractionated by electro-
phoresis on 4.5% polyacrylamide gels [37.5:1 (w/w) acryl-
amide/bis-acrylamide] containing Tris borate buffer
(45mM Tris borate buffer pH 8.3). The free and bound
RNAs were visualized using autoradiography.
Co-immunoprecipitation and RT–PCR
The lysate from EV71-infected RD cells transfected pFlag-
CMV2-FBP1 over expression plasmid for use in
co-immunoprecipitation assays were collected at 6h
post-infection. The cell extract was pre-cleared by incuba-
tion on ice for 1h with protein A-agarose (50% in lysis
buffer). The non-speciﬁc complexes were collected by cen-
trifugation at 10000g at 4 C for 10min. The supernatants
were used in the immunoprecipitation assay. Hundred
microliters of pre-cleared lysate was diluted with 450ml
of lysis buffer and added to 15ml of ﬂag antibody/HA
antibody/mouse IgG, and then incubated on ice 2h.
Pre-washed protein A-agarose was added to each sample,
which was then incubated on ice for 1h. Immune
complexes were collected by centrifugation at 1000g at
4 C for 5min and washed three times with lysis buffer.
Each pellet or 100ml pre-cleared lysate (total RNA) was
re-suspended in 400ml of proteinase K buffer (100mM
Tris–HCl, 12.5mM EDTA, 150mM NaCl, 1% SDS, pH
7.5) and incubated with 100mg of pre-digested proteinase
K for 37 C, 30min. RNA was extracted with TRIzol LS
Reagent, dried and re-suspended in 20ml DEPC H2O.
RT–PCR was used as a Reverse-iT One-Step RT–PCR
kit (ABgene, Surry, UK) and either primer to either
EV71 50-UTR 50-(GGCCCCTGAATGCGGCTAAT)
and 50-(GTTTGATTGTGTTGAGGGTC) or primers
speciﬁc to ribosomal protein S16 50-(GCGCGGTGAGG
TTGTCTAG) and 50-(GAGTTTTGAGTCACGATGG).
Fluorescence microscopic analysis
RD cells were seeded on 20-mm coverslips to 80%
conﬂuency and were infected with EV71 strain 4643/
TW/1998 at multiplicity of infection (m.o.i.) of 40. After
culturing, cells were washed with PBS, and ﬁxed with
3.7% formaldehyde for 20min at room temperature.
Cells were then washed with PBS and permeabilized
using 0.4% Triton X-100 for 5min at room temperature.
After another PBS wash, cells were incubated in blocking
solution (PBS contained 0.5% BSA) for 1h at room tem-
perature and immunostained with anti-FBP1 (mouse
monoclonal, diluted 1:50; BD Biosciences), anti-EV71
2B (diluted 1:200; provided by Dr Jim-Tong Horng) for
2h at 37 C. After they had been washed three times with
PBS, cells were incubated with Alexa Fluor
488-conjugated goat anti-mouse IgG (Invitrogen) and
Alexa Fluor 568 goat anti-rat IgG for 1h at room tempera-
ture. The nucleus was stained using Hoechst 33258 (1:500
dilution) for 20min according to a method described else-
where (31). The cells were then observed under a confocal
laser-scanning microscope (Zeiss; LSM 510 NLO).
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plasmid
Two sets of RD cells were grown in a 6-well plate (2 10
5
cells per well) for 24h and then transfected with FBP1
siRNA or pFlag-CMV2-FBP1 (pFLAG/FBP1) expression
plasmid (4mg per well) according to the manufacturer’s
protocol, using Lipofectamine 2000 (Invitrogen) as the
transfection reagent. The sequence of FBP1 siRNA is
50-(UUACAAUGCCAACAGCAAAUCUUGG)
(Invitrogen; FBP1-HSS113124).
Dicistronic or monocistronic expression assay
For dicistronic expression assay, RD cells were transfected
with siRNA against FBP1. After 3 days, dicistronic con-
struct pRHF-EV71 and FBP1 siRNA were co-transfected
into RD cells. After 2 days, cell extracts were prepared in a
passive buffer (Promega) and examined for Renilla
luciferase (RLuc) and Fireﬂy luciferase (FLuc) activity in
a Lumat LB9507 bioluminometer using a dual-luciferase
reporter assay (Promega) according to the manufacturer’s
instructions.
Preparation of HeLa cells translation extracts
Approximately 4.5 10
5 cells/ml of HeLa cells were main-
tained in DMEM (GIBCO) with 10% FBS at 37 C. Two
liters of HeLa cells were collected and centrifuged at 2800g
for 10min at 4 C. After washing three times with cold
PBS, 1.5 volume hypotonic lysis buffer (10mM HEPES–
K O Hp H7 . 6 ,1 0 m MK O A c ,1 . 5 m MM g ( O A c ) 2,2 m M
D T T )w a sa d d e dt or e - s u s p e n dc e l lp e l l e t s ,w h i c hw e r e
then kept on ice for 10min. Cells were homogenized with
 100 strokes of a 25G 3/8inch needle and checked using
trypan blue stain to ensure that the percentage of cell lysis
was over 95%. The extracts were centrifuged at 10 400g
for 20min at 4 C. The supernatant was then collected, the
extracts frozen in liquid nitrogen and then stored at a
temperature of  80 C.
In vitro IRES activity assay
In vitro IRES activity assay was performed in ﬁnal volume
of 25ml which contained 0.5mg RNA, different amount of
recombinant FBP1 proteins, 80mg HeLa cells translation
extracts and 20% rabbit reticulocyte lysate (RRL)
(Promega). The procedure of in vitro IRES activity assay
is followed Rabbit Reticulocyte Lysate System (Promega).
The mixtures were incubated at 30 C for 90min and FLuc
activity was measured by Luciferase Assay System
(Promega).
Virus translation and metabolic radiolabeling
Forty-eight hours after FBP1 and NC siRNA transfec-
tion, 2 10
5 RD cells were seeded into 12-well plates for
24h. The cells were then challenged with EV71 (strain
4643/TW/1998) at a multiplicity of infection of an m.o.i.
40 per cell. The virus was adsorbed for 1h at 37 C. Then
the medium was replaced with DMEM without methio-
nine, and incubation was continued at 37 C. At vari-
ous times post-infection, the medium was replaced with
a medium with
35S-methionine labeling (50mCi/ml).
After 1h of labeling, the cells were washed with PBS
and lysed with lysis buffer CA630 (150mM NaCl, 1%
CA630, 50mM Tris-base, pH 8.0). Cell lysates were
isolated by centrifugation at 10000g for 10min at 4 C,
and the supernatants were collected, immediately frozen
and stored at  80 C. Radiolabeled proteins were sub-
jected to 12% SDS–PAGE, transferred to a PVDF
membrane, and detected by autoradiography.
Baculovirus expression system
FBP1 recombinant proteins were produced by the baculo-
virus expression system. The pBacPAK8-MTEGFP-FBP1
plasmid DNA and baculovirus DNA were co-transfected
into Sf9 cells using the BD BaculoGoldTM Transfection
Kit (BD Biosciences). These cells were maintained in
Grace’s insect medium (Caisson) and contained 10%
FBS. The supernatant was collected after 4 days, and
then 5 10
4 cells were infected and seeded into a 96-well
plate for selecting a single virus clone. Cell extracts were
collected and western blot was used to check the protein
expression of FBP1. For large-scale ampliﬁcation of FBP1
recombinant proteins, 1 10
6 cells/ml were infected with
1m.o.i. recombinant virus in 400ml Grace’s insect medium
and then incubated at 27 C for 4 days. The FBP1-His
fusion protein was puriﬁed by HiTrap Kit (Pharmacia).
Generation of truncated virus in the deletion linker region
of EV71
The pCR-XL-Topo plasmid (Invitrogen) including the
full-length EV71 wild-type genome (TW/2231/98) was
constructed. Deletion linker region of EV71 was generated
using the PCR and formed infectious plasmid. Using
MEGAscript T7 in vitro transcription kit (Ambion)
produced deletion linker region viral RNA. The truncated
viral RNA was transfected to 3.5 10
5 RD cells in six
wells. After the RD cells shown cytopathic effect, we col-
lected the supernatant to centrifuge the recombinant virus.
Virus growth and plaque assay
After FBP1, negative control (NC) siRNA, and expression
plasmid (pFLAG/FBP1) transfection for 48h, 2 10
5 RD
or SF268 cells were seeded into 12-well plates and
incubated for 24h. Then the cells were infected with
EV71 (strain 4643/TW/1998) at an m.o.i. of 40 or 0.1
per cell. The virus was adsorbed for 1h at 37 C. At
various times post-infection, the supernatants of the cell
culture medium and cell lysates were collected to deter-
mine viral titers by performing a plaque assay on the
RD cells. At the end time point, cell lysates were collected
to measure FBP1 knockdown and expression level.
RESULTS
FBP1 associates with the enterovirus 71 50-untranslated
region
RNA chromatography, followed by MALDI-TOF mass
spectrometry (MALDI-TOF MS) identiﬁed FBP1 as a
novel EV71 50-UTR-associated protein (18,22). To
conﬁrm the speciﬁc interaction between EV71 50-UTR
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was incubated with SF268 (human glioblastoma) cell
lysate. Streptavidin beads were used to capture biotiny-
lated RNA and its associated proteins. Western blot
using an antibody speciﬁc to FBP1 was applied for the
detection of the amount of FBP1 in the pull-down cell
lysate. Increasing amounts of non-biotinylated EV71
50-UTR or yeast tRNA were also added to the lysates for
a competition assay. Figure 1A shows the interaction of
FBP1 with the biotinylated EV71 50-UTR. The FBP1
decreased upon addition of increasing amounts of non-
biotinylated EV71 50-UTR (Figure 1A, lanes 2–5).
However, when different amounts of non-speciﬁc RNA
(yeast tRNA) were added, no signiﬁcant change was ob-
served for FBP1 in the pull-down cell lysates (Figure 1A,
lanes 7–10).
To determine whether the interaction of FBP1 with
EV71 50-UTR occurred in a cell-type speciﬁc manner, in
addition to SF268 cell lysate, another neural cell line,
SK-N-MC (human neuroblastoma) or lysates from two
non-neural cells, RD (human embryonal rhabdomyosar-
coma) and Vero (monkey kidney epithelial) were used for
the RNA pull-down assay. These cell lines are commonly
used for cultivating enterovirus. The results in Figure 1B
show that the association of FBP1 with EV71 50-UTR
occurred in all cell lines tested (Figure 1B, lanes 5, 10,
15 and 20), indicating that this association is likely to be
a common interaction among different cell lines.
Interaction regions in the viral 50-untranslated region and
in FBP1 protein
The EV71 50-UTR contains different structure domains: a
cloverleaf structure at the 50-end, a several stem loop (do-
main II–VI), and a linker region within the IRES domains.
To elucidate the RNA determinants responsible for FBP1
binding, a series of truncated forms of viral RNAs con-
taining different regions of 50-UTR, (Figure 2A, the sec-
ondary RNA structure was drawn by M-FOLD), were
transcribed and labeled with biotin in vitro. An RNA–
protein pull-down assay was performed as described in
‘Materials and Methods’ section using Streptavidin
beads to capture RNA associated proteins in RD cell
lysate. Subsequently, western blot using an antibody spe-
ciﬁc to FBP1 was applied to examine the RNA–protein
interactions. The results in Figure 2B show that biotiny-
lated RNA 91–745nt (Figure 2B, lane 14), 453–745nt
(lane 22), 566–745nt (lane 24) and 637–745nt (lane 26)
interacted with FBP1, but the other RNAs did not. The
results suggest that FBP1 may interact with linker region
downstream of the EV71 IRES (637–745nt).
To conﬁrm the results obtained by bead binding assays,
an electrophoretic mobility shift assay was performed
using radiolabeled RNAs. The
32P-labeled 1–745 or
637–745nt EV71 RNAs were allowed to form complexes
with recombinant FBP1 that was puriﬁed from a baculo-
virus expression system, and the resulting complexes
were analyzed by native gel electrophoresis (Figure 2C).
Figure 1. FBP1 associates with EV71 50-UTR. (A) FBP1 association with EV71 50-UTR was conﬁrmed by competition assay and western blot. The
biotinylated RNA association proteins were loaded to SDS–PAGE (12%). FBP1 antibody was utilized in this western blot. Various amounts of
unlabeled EV71 50-UTR and yeast tRNA RNA probe were added to compete with the biotinylated EV71 50-UTR probe interacting with FBP1 in
RD cell lysate. Lanes 1 and 6 contained cell lysate (200mg) only. An unlabeled EV71 50-UTR RNA probe was used in the competition assay (lanes
3–5), and an unlableled yeast tRNA probe was utilized (lanes 8–10). (B) EV71 50-UTR associates with cellular protein FBP1 in the various cell lines,
SK-N-MC, SF268, RD and Vero cell. Cell lysates are shown in lanes 1, 6, 11 and 16. Various cell extracts were incubated in the absence of RNA
(lanes 2, 7, 12 and 17) or in the presence of biotin-16-UTP only (lanes 3, 8, 13 and 18), non-biotinylated EV71 50-UTR (lanes 4, 9, 14 and 19) or
biotinylated EV71 50-UTR (lanes 5, 10, 15 and 20). After the streptavidin beads were washed, the EV71 50-UTR associated proteins were detected
using SDS–PAGE (12%). FBP1 protein was analyzed by western blot with anti-FBP1 cellular protein antibody.
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EV71 RNAs formed a complex with FBP1 (Figure 2C,
lanes 2 and 6). Subsequently, to further demonstrate
that the 637–745nt fragment is the main FBP1 bind-
ing site, competition binding assays were performed.
RNP complexes were formed ﬁrst with both
32P-labeled
1–745 or 637–745nt EV71 RNAs and subjected to com-
petition with cold competitor RNAs, 1–745 or 636–745nt
EV71 RNAs (Figure 2C, lanes 3, 4, 7 and 8). These results
indicated that the 50-UTR of EV71 binds to FBP1, and
Figure 2. Identiﬁcation of interaction regions in EV71 50-UTR for FBP1. (A) M-FOLD software was applied to draw the EV71 50-UTR RNA
secondary structure. The numbers indicate the ﬁrst and the last nucleotides in each stem-loop. The IRES element is from 1 to 636nt, and the linker
region is from 637 to 745nt in EV71 50-UTR. (B) Identiﬁcation of FBP1 interaction region in EV71 50-UTR. Various length, truncated forms of
RNA probes, as indicated, were transcribed in vitro and biotinylated. RD cell lysates were incubated with these biotinylated RNA probes (lanes 2, 4,
6, 8, 10, 12, 14, 16, 18, 20, 22, 24 and 26). Non-biotinylated RNA probes were also applied in this assay as controls (lanes 1, 3, 5, 7, 9, 11, 13, 15, 17,
19, 21, 23 and 25). The RNA and protein complex associated beads were pulled down by streptavidin beads and resolved in the SDS–PAGE (12%).
An anti-FBP1 antibody was applied to detect FBP1 in the pull-down complex. (C) Conﬁrmation of FBP1 direct interaction in EV71 50-UTR. The
50fmol
32P-radiolabeled full-length EV71 50-UTR 1–745nt RNA (
32P-EV71 1–745) (lanes 1–4) and 636–745nt RNA (
32P-EV71 636–745) (lanes 5–8)
were utilized in electrophoretic mobility shift assays. Lanes 1 and 5 contained only
32P-radiolabeled RNA probe (lanes 1 and 5). The 2pmol
recombinant protein FBP1 was incubated with
32P-radiolabeled RNA probe and 10pmol tRNA (lanes 2 and 6). The 2pmol cold EV71 1–745nt
RNA probe (EV71 1–745), and cold EV71 636–745 RNA probe (EV71 636–745) (lanes 4 and 8) competed with 50 fmoles
32P-radiolabeled RNA
probe in present recombinant FBP1. (D) EV71 50-UTR RNA was pulled down with FBP1 from EV71-infected cell lysate. Anti-ﬂag antibody was
used in the immunoprecipitation assay. The RNA was extracted and subjected to the RT–PCR using EV71 50-UTR-speciﬁc or RPS16-speciﬁc
primers. Cell lysate without immunoprecipitation was used for RNA extraction (lanes 1 and 6) as an RT–PCR control. Anti-Flag antibody was
incubated with 200mg infected cell lysate and then underwent RNA extraction and RT-PCR analysis (lanes 2 and 7). The same reaction with
anti-HA antibody, mouse IgG or without antibody was performed used as a negative control (lanes 3, 4, 5, 8, 9 and 10). H2O as a template was an
RT–PCR negative control (lanes 6 and 12). FBP1 protein binds to the EV71 50-UTR RNA but not to the control RNA (RPS16).
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recruitment.
To conﬁrm that FBP1 interaction with EV71 IRES also
occurred in infected cells, FLAG/FBP1 was over-
expressed in RD cells, which were challenged by EV71
at 40m.o.i. The pull-down reaction was subjected to
RNA extraction and analysis. The RT-PCR results
obtained using EV71 50-UTR-speciﬁc primers are shown
in Figure 2D. Immunoprecipitation with ﬂag antibody co-
precipitated EV71 50-UTR (Figure 2D, lane 2), conﬁrming
that FBP1 interacts with EV71 50-UTR. No speciﬁc band
representing EV71 50-UTR or ribosomal protein S16
(RPS16) was detected when the reaction proceeded with
anti-HA antibody (Figure 2D, lanes 3 and 9), mouse IgG
(Figure 2D, lanes 4 and 10), without anti-ﬂag antibody
(Figure 2D, lanes 5 and 11). H2O was a negative control
for RT–PCR (Figure 2D, lanes 6 and 12). The combined
results of Figure 2C and D demonstrate that FBP1 inter-
acts with EV71 50-UTR both in vivo and in vitro.
The region in FBP1 that interacts with EV71 50-UTR
FBP1 is a nuclear protein with 644 amino acids long. It
contains four KH-type RNA binding motifs ﬂanked by
N- and C-terminal domains (Figure 3A). The C-terminal
domain can perform translational activation (32).
Plasmids containing different truncated forms of FBP1
fused with FLAG (as illustrated in Figure 3A) were trans-
fected into RD cells. The cell lysates were used for RNA–
protein pull-down assays. The amounts of FBP1 and its
truncated forms were visualized by western blot using an
anti-ﬂag antibody (Figure 3B). Streptavidin beads cap-
tured biotinylated EV71 50-UTR and its associated full-
length FBP1 (Figure 3B, lane 3) and its truncated forms
100–443 (lane 6), 185–644 (lane 15), 275–644 (lane 18) and
275–443 amino acids (lane 27), but not 1–164 (lane 9),
1–251 (lane 12), 376–644 (lane 21) and 185–339 amino
acids (lane 24). The results demonstrated that the KH3
and KH4 domains of FBP1 are sufﬁcient for binding with
EV71 50-UTR.
FBP1 redistributes to different subcellular compartments
upon EV71 infection
While FBP1 is considered a nuclear protein, EV71 repli-
cation occurs in cytoplasm. The localization of FBP1 on
EV71 infection was examined to determine whether FBP1
can associate with the viral IRES in the cytoplasm. When
RD cells were infected with 40m.o.i. EV71, viral protein
synthesis reached a peak at 6h post-infection. Therefore,
the subcellular distribution of FBP1 was analyzed by ﬂuor-
escence confocal microscopy at 2, 4, 6 and 8h post-
infection. EV71-infected cells were identiﬁed by staining
them with an antibody against the viral 2B protein. The
results showed that EV71 replica t i o no c c u r r e di nc y t o p l a s m
as expected (Figure 4A-20). In mock-infected cells, FBP1 is
mainly localized in the cell nucleus (Figure 4A-5); however,
it redistributed to the cytoplasm when the cells were
challenged with EV71 (Figure 4A-15, 20, 25).
FBP1 is a nuclear protein, containing three NLS, a clas-
sical bipartite NLS in the N-terminal domain (63–78
amino acids), a typical a4 NLS in the central domain
(366–386 amino acids), and one tyrosine-rich motif
(YM) in the C-terminal domain of FBP1 (531–634
amino acids). To examine which NLS is involved in the
redistribution of FBP1 from the nucleus to the cytoplasm
during infection, plasmids containing different NLS of
FBP1 fused with triple GFPs were transfected into cells.
When a plasmid containing triple GFPs only was trans-
fected into cells, the GFP was found located in the cyto-
plasm (Figure 4B-4). In mock-infected cells, triple
GFPs with bipartite NLS were localized in the nucleus
(Figure 4C-5), but a4 NLS (Figure 4D-5), and YM NLS
(Figure 4E-5) were localized in the nucleus and the cyto-
plasm. All NLS of FBP1 were involved redistribution to
the cytoplasm upon virus challenging (Figure 4C-10,
4D-10 and 4E-10). The data indicate that three NLS of
FBP1, bipartite NLS, typical a4 NLS, and YM NLS may
all participate in FBP1 redistribution.
FBP1 positively regulates IRES-dependent translation of
EV71 using luciferase reporter assays and an in vitro
IRES activity assay
FBP1 can interact with IRES which participates in EV71
viral protein synthesis. Therefore we examine the role of
FBP1 on EV71 IRES activity and translation. An RNA
interference method was applied to knockdown FBP1 ex-
pression in cells. A dicistronic IRES activity reporter
plasmid (pRHF-EV71) was used to evaluate EV71 IRES
activity in siRNA-treated cells. The ﬁrst cistronic (RLuc)
translation is cap-dependent, while the translation of the
second cistronic (FLuc) is dependent on EV71 IRES
activity (Figure 5A). The ratio of FLuc expression to
RLuc expression yields the IRES activity. NC siRNA or
siRNA against FBP1 was transfected into RD cells. A
dicistronic reporter plasmid was then co-transfected to
the cells. After 48h post-transfection, cell lysates were col-
lected and used to calculate the ratio of FLuc to RLuc
activity. EV71 IRES activity signiﬁcantly decreased to
74.6% (P<0.001) in FBP1 knockdown cells in compari-
son to that of NC siRNA-treated cells (Figure 5A). The
knockdown efﬁciency of FBP1 is illustrated in the lower
panel of Figure 5A. As FBP1 knockdown may also inter-
fere with the cap-dependent activity, a cap-dependent
reporter plasmid (pRH) was transfected into cells and
the RLuc value that presents cap-dependent activity was
then measured. Knockdown of endogenous FBP1 protein
in RD cells slightly decreases cap-dependent activity to
88% (Figure 5B). As a nuclear event, such as use of the
splice site or cryptic promoter in the IRES sequence of the
dicistronic construct may interfere with the ratio of FLuc/
RLuc, an in vitro transcribed monocistronic mRNAs con-
taining the EV71 50-UTR (EV71-50-UTR-FLuc) were
transfected to FBP1 knockdown RD cells instead. The
FLuc value represents EV71 IRES activity. Cell lysates
were collected and analyzed to determine FLuc activity
after 6h of monocistronic mRNAs transfection. The
EV71 IRES activity in FBP1 knockdown cells signiﬁcantly
decreased to 65% (P<0.001) in comparison to that of NC
siRNA-transfected cells (Figure 5C). The lower panel of
Figure 5C displays siRNA knockdown efﬁciency of FBP1.
The results indicate that FBP1 may positively regulate
Nucleic Acids Research, 2011,Vol.39, No. 22 9639EV71 IRES-mediated translation. To prove that FBP1
plays a positive role in EV71 IRES activity, an in vitro
IRES activity assay was performed. Different amounts
of recombinant FBP1 protein were added into a mixture
containing 20% RRL, HeLa cell translation extracts, and
a monocistronic mRNA with EV71 IRES (EV71-50-
UTR-FLuc). The 0.5ng recombinant protein FBP1 and
1ng recombinant protein FBP1 enhanced in vitro EV71
IRES activity to 111% and 178% (P<0.05), respectively
(Figure 5D). PTB was used as a positive control in this
in vitro IRES activity assay. The result strongly indicates
that FBP1 is a novel positive ITAF for EV71 IRES.
We also examined viral protein synthesis in NC siRNA
or FBP1 siRNA-treated cells. The transfected cells
were challenged with EV71 (40m.o.i.) and pulse-labeled
with
35S-methionine at different post-infection times.
Figure 3. Identiﬁcation of interaction domains in FBP1 for EV71 50-UTR. (A) Schematic diagram of various truncated forms of FBP1. The black
boxes indicate KH domains. The N-terminal domain and the C-terminal domain are as indicated. Fused ﬂag tags at the N-terminals of various
truncated forms of FBP1 were applied in a pull-down assay. The numbers of the truncated form FBP1 indicate ﬁrst and last amino acids. (B) Map
interaction regions in FBP1 for EV71 50-UTR. Wild-type FBP1 (lane 1) or various truncated forms of FBP1 (lanes 4, 7, 10, 13, 16, 19, 22 and 25)
expression plasmid were transfected into RD cells. Cell extracts from various transfected forms of FBP1 were collected and incubated with
biotinylated EV71 50-UTR RNA probe (lanes 3, 6, 9, 12, 15, 18, 21, 24 and 27) or non-biotinylated RNA probe (lanes 2, 5, 8, 11, 14, 17, 20, 23
and 26). Western blot using anti-Flag and anti-FBP1 antibodies was applied to examine protein expression. The RNA–protein complex with beads
was resolved for SDS–PAGE (12%).
9640 Nucleic Acids Research, 2011,Vol.39, No. 22As expected, the siRNA against FBP1 slightly decreases
the cap-dependent translation (Figure 5E, lanes 1 and 2),
but EV71 infection shut down host protein synthesis and
the expression of the viral protein became dominant.
EV71 viral protein synthesis was lower in FBP1 knock-
down cells than in control cells, indicating that FBP1
enhanced viral protein synthesis (Figure 5E, lanes 3–6).
These data reveal that FBP1 may participate in viral trans-
lation as a positive modulator.
FBP1 outcompeted the binding of FBP2 to the linker
region of EV71 IRES
A previous study showed that FBP2 acted as a negative
ITAF (22), whereas in this study, FBP1 is identiﬁed as a
novel positive regulator for EV71 IRES activity. The data
indicate that both FBP1 and FBP2 can interact with the
linker region (637–745nt) in EV71 50-UTR (Figure 6A,
lane 2). To investigate whether FBP1 can compete with
FBP2 for IRES binding, an in vitro competition binding
assay was performed. RD cell lysate and a biotinylated
RNA probe were ﬁrst incubated together. Then,
increasing amounts of recombinant FBP1 were added to
the assay. The results showed that recombinant protein
FBP1 outcompeted FBP2 in RD cell lysate for 50-UTR
IRES binding (Figure 6B, lanes 2–6). The same results
were obtained when using the linker region (636–745nt)
RNA probe (Figure 6B, lanes 8–12). These results suggest
that FBP1 may act as a positive IRES regulator through
competing with the negative ITAF FBP2 for binding to
the linker region.
Lower virus replication rates in FBP1 knockdown cells
To study the effect of FBP1 on EV71 replication, RD cells
were ﬁrst treated with NC siRNA or FBP1 siRNA and
Figure 4. FBP1 localized to cytoplasm upon EV71 infection. (A) FBP1 localization in EV71-infected cells. Mock infected or infected with 40m.o.i.
EV71 after 2, 4, 6 and 8h post-infection RD cells were ﬁxed and stained with antibodies against FBP1 and EV71 viral protein 2B. Panels 1, 6, 11, 16
and 21 were used anti-2B antibody and were examined with a Rhodamin ﬁlter; panels 2, 7, 12, 17 and 22 were treated with anti-FBP1 antibody and
examined with a FITC ﬁlter; panels 3, 8, 13, 18 and 23 present Hoechst 33258 examined with a 40,60-diamidino-2-phenylindole (DAPI) ﬁlter. Panels
4, 9, 14, 19 and 24 show mock-infected and EV71-infected RD cell morphology in phase, and panels 5, 10, 15, 20 and 20 show merged Rhodamin,
FITC and Hoechst images. (B) Triple-GFP localization in mock-infected RD cells. A FITC signal was used to detect the triple-GFP location in cells
(panel 1); Hoechst 33258 stained the nucleus of RD cell (panel 2). Triple-GFP transfected RD cells morphology shown in phase (panel 3), and the
merged images shown as a control (panel 4). (C–E) Triple-GFP fused with FBP1 bipartite NLS, a4 NLS and YM NLS localize in RD cells upon
EV71 infection. Triple-GFP fused various NLSs of FBP1 were transfected in RD cells and then challenged with EV71. Panels 1 and 6 were treated
with anti-3A antibody and examined with a Rhodamin ﬁlter; panels 2 and 7 show cells examined with a FITC signal; panels 3 and 8 present Hoechst
33258 examined with a DAPI ﬁlter. Mock-infected and EV71-infected RD cell morphology are shown in phase (panels 4 and 9), and the merged
images are shown as a control (panels 5 and 10).
Nucleic Acids Research, 2011,Vol.39, No. 22 9641then infected with a high (40m.o.i.) or low (0.1m.o.i.) titer
of EV71. Viral yields were measured at various post-
infection times using plaque assay. Lower replication rates
were observed in FBP1 knockdown cells than in NC
siRNA-treated RD cells with high or low m.o.i. viral in-
fection (Figure 7A and B), supporting the view of a
positive role for FBP1 during EV71 infection. To assay
whether the effect of FBP1 on viral replication is cell-type
speciﬁc, these experiments were repeated in SF268 cells.
The data show that viral replication rates in FBP1
siRNA-treated SF268 cells are lower than in NC cells
(Figure 7C and D), indicating that FBP1 plays a
positive role in EV71 replication. We generated a recom-
binant virus, DEL-637-745-EV71, which lacked FBP1-
binding site (the linker region in 50-UTR), to understand
whether the interaction of FBP1 and the linker region
contributes to the lower viral growth rate in FBP1
knockdown cells. The mutant virus was used to infect
NC or FBP1 siRNA-treated RD cells. Viruses from the
debris and the supernatant were collected together at 6,
12, 18 and 24h intervals post-infection. The virus titer was
determined by plaque assay. There is no signiﬁcant differ-
ence in the growth rate between NC or FBP1 siRNA-
treated RD cells (Figure 7E), which suggests that the regu-
lation of FBP1 on EV71 viral replication may be due to
the interaction of the linker region.
DISCUSSION
EV71 and other picornaviruses with a single positive-
strand viral genome can initiate the synthesis of a viral
polyprotein directly upon entry into the cell. The mechan-
ism relies on IRES that recruits the ribosomal subunit in a
process that is assisted by cellular ITAFs. Previously, we
identiﬁed several cellular factors interacting with EV71
IRES elements and demonstrated that FBP2 acts as a
negative ITAFs during translation (22). We now analyzed
the interaction between FBP1 and the EV71 IRES. We
demonstrated that FBP1–EV71 interaction can occur both
in non-neural and neural cells (Figure 1B). Our results
demonstrate that FBP1 is a positive regulator of EV71
IRES activity and depletion of FBP1 in cells produced a
lower viral yield.
Our results indicate that FBP1 interacts with the linker
region (636–745nt) in EV71 IRES. Although this region is
implicated in viral IRES-mediated translation, and facili-
tates viral growth, secondary structure prediction software
detected no secondary structure in this region (Figure 2A)
and its role during translation remained unknown. One
report indicated that deletions of 6–125nt in the linker
region of the swine vesicular disease virus, which also
belongs to the family Picornaviridae, had a signiﬁcantly re-
duced plaque diameter and grew to a signiﬁcantly lower
Figure 4. Continued.
9642 Nucleic Acids Research, 2011,Vol.39, No. 22Figure 5. Viral IRES activity and viral protein synthesis were positively regulated by FBP1. (A) Schematic diagram of dicistronic reporter
plasmids pRHF-EV71. Plasmid expresses dicistronic mRNA, consisting of cytomegalovirus (CMV) promoter, the ﬁrst cistron RLuc gene, the
EV71-50-UTR and the second cistron FLuc. A hairpin (H) is inserted downstream of the ﬁrst cistron to prevent ribosome read-through. RD
cells were transfected siRNA against FBP1. After 3 days, dicistronic construct pRHF-EV71 and FBP1 siRNA were co-transfected into RD cells.
After 2 days, the RLuc and FLuc activity in cell lysates were analyzed. The bars in the histogram represent FLuc/RLuc activity percentages.
Experiments were performed in triplicate to obtain the bar graph. Western blotting was utilized analyze the expression levels of FBP1 and actin.
(B) Schematic diagram of cap-dependent reporter pRH. RD cells were transfected FBP1 siRNA ﬁrstly. After 3 days, cap-dependent reporter
construct pRH and FBP1 siRNA were co-transfected into RD cells. After 2 days, the RLuc activity in cell lysates were analyzed. Western
blotting was utilized analyze the expression levels of FBP1 and actin. (C) Schematic diagram of monocistronic reporter EV71-50-UTR-FLuc.
Monocistronic mRNA containing EV71 IRES and FLuc was transfected to cells pre-treated with FBP1 siRNA or NC siRNA. At 6h
post-transfection, the RD cell lysate was assayed for FLuc activity. Cells were harvested, lysed and western blotted for FBP1 and actin. (D)
In vitro IRES activity assay was performed contained monocistronic reporter RNA (EV71-50-UTR-FLuc), different amounts recombinant FBP1
proteins or PTB, HeLa cells translation extracts and 20% RRL. The mixtures were incubated and measured FLuc activity. (E) Viral proteins
synthesis in FBP1 knockdown cells. RD cells transfected with of NC siRNA or FBP1 siRNA were challenged with EV71 and subjected to a
pulse-labeling assay. Protein synthesis in mock-infected (lanes 1 and 2), and EV71-infected cells were examined by
35S-methionine pulse-labeling at
various times (lanes 3–6). Western blot analysis of FBP1 protein knockdown efﬁciency was performed (lower panels). (*P<0.05, **P<0.01 and
***P<0.001, Student’s two-tailed unpaired t-test).
Nucleic Acids Research, 2011,Vol.39, No. 22 9643titer (33). Another study found that the region around the
AUG of the poliovirus IRES is predicted to base pair to a
region near the 30-end of the 18S rRNA (34–37). The
linker region may facilitate the formation of an IRES
tertiary structure (38). Our results suggest that the linker
region could be involved during translation by directly
recruiting the positive ITAF FBP1. However, the precise
effect of FBP1 recruitment during internal ribosome re-
mains to be established. Further study are currently under-
taken to understand how the linker region (637–745nt)
interacts with cellular factors and how this interaction
affects ribosome recruitment.
FBP1 contains four KH domains and acts as a regulator
of c-myc expression. Structure studies using nuclear mag-
netic resonance (NMR) spectroscopy determined that the
KH3 and KH4 domains of FBP1 interacting with a 29-bp
fragment of DNA from a FUSE (23). Here we reported
that the KH3 and KH4 domains of FBP1 are sufﬁcient for
binding with EV71 IRES (Figure 3B). Most of the cellular
proteins modulating IRES activity contained multiple
RNA binding motifs and domains (39–41). FBP1 may
act through the direct binding of EV71 IRES, as shown
in Figure 2C. Nevertheless, the interaction of FBP1 with
the IRES could also involve with other cellular proteins. Figure 5. Continued.
Figure 6. FBP1 outcompeted the binding of FBP2 to EV71 IRES. (A) The associated region in EV71 50-UTR with FBP1 and FBP2. The linker
region (636–745nt) of the EV71 50-UTR RNA probe was transcribed in vitro and biotinylated. RD cell lysates were incubated with a
non-biotinylabeled RNA probe (lane 1) or a biotinylated RNA probe (lane 2). After being pulled down by Streptavidin beads, the protein
complex was resolved in the SDS–PAGE (12%). Western blot was then performed to detect FBP1 and FBP2 in the pull-down complex. (B) The
competition of FBP1 and FBP2 for IRES binding. The pull-down assay was performed here. The eluted proteins were subjected to SDS–PAGE
(12%). Various amounts (mg) of FBP1 recombinant protein were added to compete with FBP2 of the cell lysate in interacting with the biotin-labeled
EV71 50-UTR RNA probe (EV71 1–745nt) (lanes 2–6) and the linker region RNA probe (EV71 636–745nt) (lanes 8–12). In the negative control,
non-biotinylated RNA probes were applied the reaction (lanes 1 and 7). Antibodies against FBP1 and FBP2 were utilized in a western blot analysis.
9644 Nucleic Acids Research, 2011,Vol.39, No. 22Figure 7. EV71 exhibits a lower growth rate in FBP1 knockdown cells. (A and B) EV71 growth rate in FBP1 knockdown RD cells. RD cells were
treated with NC siRNA or FBP1 siRNA for 48h and then challenged with EV71 40 or 0.1m.o.i. (C and D) EV71 growth rate in SF268 FBP1
siRNA-treated cells. SF268 cells were treated with NC siRNA or FBP1 siRNA for 48h and then challenged with EV71 at m.o.i. of 40 or 0.1. A
plaque assay was performed to measure the viral growth rate at various post-infection times. The lower panels demonstrate that FBP1 was knocked
down following siRNA treatment. (E) Growth curves for truncated virus DEL-637-745-EV71 in NC and FBP1 siRNA-treated RD cells. RD cells
were transfected NC and FBP1 siRNA and then infected with truncated virus DEL-637-745-EV71 at m.o.i. of 40. Viruses from the debris and the
supernatant were collected together at 6, 12, 18 and 24h post-infection. The virus titter was determined by plaque assay. The number shown in the
vertical axis represents the virus titter as the log10 PFU per ml. The lower panels demonstrate that FBP1 was knocked down following siRNA
treatment. (*P<0.05, **P<0.01, Student’s two-tailed unpaired t-test).
Nucleic Acids Research, 2011,Vol.39, No. 22 9645FBP1 is mainly localized in the nucleus; however, it
needs to re-localize to the cytoplasm to stimulate viral
translation. Our data show that FBP1 was redistributed
to the cytoplasm when the cells were challenged with EV71
(Figure 4A). A number of studies found that nuclear cel-
lular proteins are re-localized in the cytosol upon virus
infection. Several ﬁndings also revealed that cellular
shuttling proteins such as hnRNP A1, K and C co-localize
with the viral genome (42). Distribution of nuclear protein
may be a consequence of an alteration of the nuclear pore
complex (NPC) structure caused by the polio-viral prote-
ase, 2A (29,43). Several nucleoporins, including Nup 153,
98 and 62 are cleaved by the protease and may result in the
inactivation of speciﬁc nuclear transport functions, and
the redistribution of nuclear proteins (43,44). However,
the mechanism by which EV71 viral proteases affect the
nucleo-cytoplasmic transport needs further investigation.
Our results show that the three NLS of FBP1, (bipartite
NLS, typical a4 NLS and YM NLS) all participated in
FBP1 redistribution in EV71 infect cells (Figure 4C, D
and E). An hypothesis may be that the virus blocks the
cytoplasmic-nuclear trafﬁc and accumulates FBP1 in
cytosol and stimulates viral translation (43,44).
Nuclear protein redistribution can be achieved in two
ways. One occurs when the newly synthesized nuclear pro-
teins cannot import into the nucleus because the import
pathways are impaired and unknown viral factors trap the
nuclear proteins. The other possibility is that the export of
nuclear proteins into the cytoplasm is facilitated by viral-
mediated export pathways. We used a triple-GFP system
which could examine the localization of nuclear proteins
as well as the functions of the import pathways by fusing
their designated NLS or NL domains to the triple-GFP
system (29). The triple-GFP system was a useful tool in
the examination of the accessions of a variety of cellular
transportation signals.
Many different experimental designs have been con-
structed to determine IRES activity, including the
monocistronic, dicistronic system and in vitro IRES
activity assay (12). We used the dicistronic and mono-
cistronic system to measure IRES activity in FBP1
siRNA-treated cells. Our data show that IRES activity
deceased in FBP1 knockdown cells with dicistronic
IRES activity assay (Figure 5A). Some nuclear events
may affect the CMV promoter-driven transcription. The
monocistronic mRNAs that contained the EV71 50-UTR
were alternatively transfected into RD cells. These results
together indicate that FBP1 act as a positive regulator of
EV71 IRES function (45,46). But the FBP1 siRNA may
slightly interfere with the ﬁrst reporter gene expression that
was driven by a cap-dependent translation (Figure 5B). To
address this, we transfected a monocistronic IRES RNA
into FBP1 siRNA-treated cells to determine IRES activity
(Figure 5C), and used real-time quantitative PCR to
measure transfection efﬁciency (data not show). The
transfection efﬁciency in NC or FBP1 siRNA-treated
cells was equal. Our results show that FBP1 enhanced
viral protein synthesis and is a novel positive regulator
for EV71 IRES activity (Figure 5C). EV71 IRES fused
FLuc RNA template was incubated with 10% RRL and
HeLa S10 extract and detected luciferase value as EV71
IRES activity. Recombinant protein 1ng FBP1 increased
EV71 IRES activity to 178% (P<0.05) of that of
non-FBP1 added. Another positive ITAF PTB as
positive control and negative ITAF FBP2 as negative
control were used here (Figure 5D). We also detected a
lower virus growth rate in FBP1 siRNA-treated cells.
However, we did not observe a signiﬁcant difference in
the virus growth rate between FBP1 in over-expressed
and control cells (data not show). The result may be due
to the abundance of FBP1 protein in the control cells,
which was sufﬁcient to modulate IRES activity.
Many proteins are involved in cellular RNA stability
and IRES-mediated viral translation as ITAFs. Various
cellular RNA binding proteins can modulate IRES
activity by stimulating ribosome recruitment and initiating
factor binding. Most ITAFs have been shown to enhance
viral IRES activity; however, some ITAFs repress IRES-
medicated viral translation (22). Our previous study
showed that FBP2 decreased viral IRES activity and
acted as a negative regulator for viral protein synthesis.
This study demonstrated that FBP1 can directly interact
with EV71 IRES and stimulate IRES-mediated transla-
tion. FBP1 and FBP2 belong to the same protein family
and share high amino acid sequence identity. However,
their functions in EV71 IRES are different. Here, we pro-
vide a hypothesis to explain how FBP1 acts as a positive
ITAF through its competition with a negative regulator,
FBP2. The data show that increasing the recombinant
protein FBP1 can suppress negative ITAF interaction
Figure 7. Continued.
9646 Nucleic Acids Research, 2011,Vol.39, No. 22with 50-UTR and the linker region (Figure 6B), which
supports our hypothesis.
In summary, our ﬁnding demonstrated that the cellular
protein, FBP1, can bind to the linker region (637–745nt)
of EV71 IRES and act as a novel positive ITAF. The fact
that FBP1 can increase IRES activity appears to be con-
sistent with viral IRES-mediated translation. This article
demonstrates that FBP1 is a novel positive regulator for
EV71 IRES activity and by unraveling a new network of
virus–host interactions may provide a new route for
anti-viral therapy.
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